Zacks Investment Management’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-10,673
Closed -$852K 628
2021
Q1
$852K Buy
10,673
+3,356
+46% +$262K 0.02% 380
2020
Q4
$577K Buy
+7,317
New +$429K 0.01% 405

Zacks Investment Management's CMD Position: Q2 2021 in Review

Zacks Investment Management sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 10,673 shares — an estimated $852K sold.

Zacks Investment Management first reported a position in CMD in Q4 2020 and held it in 2 quarters. The position peaked at $852K in Q1 2021. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.

  • Zacks Investment Management reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
  • Zacks Investment Management sold 10,673 Cantel Medical Corporation shares in Q2 2021, an estimated $852K.
  • Zacks Investment Management first reported a position in Cantel Medical Corporation in Q4 2020 and held it in 2 quarters.
  • Zacks Investment Management's Cantel Medical Corporation position peaked at $852K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.

Based on Zacks Investment Management's 13F filing for Q2 2021, filed 16 Aug 2021.